v3.26.1
SUBSEQUENT EVENTS (Details) - Amicus Therapeutics
Apr. 27, 2026
USD ($)
treatment
$ / shares
Mar. 31, 2026
USD ($)
Feb. 28, 2026
USD ($)
Dec. 31, 2025
USD ($)
364-Day Senior Secured Bridge Facility | Bridge Loan        
Subsequent Event [Line Items]        
Debt instrument, aggregate principal amount     $ 2,800,000,000 $ 3,700,000,000
Commitment fees that were deferred   $ 17,500,000    
Subsequent Event        
Subsequent Event [Line Items]        
Business combination, price per share (in dollars per share) | $ / shares $ 14.50      
Equity value $ 4,800,000,000      
Loans assumed and repaid $ 433,000,000.0      
Number of treatment therapies acquired | treatment 2      
Subsequent Event | 364-Day Senior Secured Bridge Facility | Bridge Loan        
Subsequent Event [Line Items]        
Debt instrument, aggregate principal amount $ 0      
Subsequent Event | Secured Debt | Senior Secured Term Loan Facility | Line of Credit        
Subsequent Event [Line Items]        
Debt instrument, aggregate principal amount 2,800,000,000      
Subsequent Event | Revolving Credit Facility | Senior Secured Revolving Credit Facility | Line of Credit        
Subsequent Event [Line Items]        
Maximum borrowing capacity $ 600,000,000.0